Evogene Ltd. (EVGN) DCF Valuation

Evogene Ltd. (EVGN) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Evogene Ltd. (EVGN) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Streamline your analysis and boost precision with our (EVGN) DCF Calculator! Utilizing authentic data from Evogene Ltd. and customizable assumptions, this tool empowers you to forecast, analyze, and value (EVGN) like a seasoned investor.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .8 1.0 .9 1.7 5.6 8.6 13.0 19.8 30.0 45.6
Revenue Growth, % 0 38.11 -10.58 80.11 236.72 51.91 51.91 51.91 51.91 51.91
EBITDA -16.0 -23.2 -27.8 -26.9 -23.2 -8.6 -13.0 -19.8 -30.0 -45.6
EBITDA, % -2120.58 -2228.65 -2988.71 -1607.94 -411.42 -100 -100 -100 -100 -100
Depreciation 2.8 2.7 2.2 2.6 2.6 7.6 11.6 17.6 26.8 40.7
Depreciation, % 367.73 262.21 240.22 154.03 46.31 89.26 89.26 89.26 89.26 89.26
EBIT -18.7 -25.9 -30.0 -29.5 -25.8 -8.6 -13.0 -19.8 -30.0 -45.6
EBIT, % -2488.31 -2490.87 -3228.92 -1761.97 -457.73 -100 -100 -100 -100 -100
Total Cash 46.9 48.2 53.9 35.4 31.1 8.6 13.0 19.8 30.0 45.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.2 2.2 1.2 .8 .7
Account Receivables, % 160.69 208.46 126.24 47.94 11.9
Inventories -.9 -1.4 .1 .6 .1 -2.7 -4.0 -6.1 -9.3 -14.1
Inventories, % -118.73 -132.6 9.89 33.79 1.35 -30.99 -30.99 -30.99 -30.99 -30.99
Accounts Payable 1.0 .9 1.5 1.0 1.8 6.5 9.8 14.9 22.6 34.4
Accounts Payable, % 132.93 82.98 157.31 61.85 31.65 75.3 75.3 75.3 75.3 75.3
Capital Expenditure -.9 -.7 -.7 -1.2 -.8 -5.6 -8.5 -12.9 -19.7 -29.9
Capital Expenditure, % -119.52 -65.58 -77.85 -69.91 -13.92 -65.45 -65.45 -65.45 -65.45 -65.45
Tax Rate, % 8.11 8.11 8.11 8.11 8.11 8.11 8.11 8.11 8.11 8.11
EBITAT -17.8 -23.1 -27.4 -26.4 -23.7 -7.8 -11.9 -18.1 -27.4 -41.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -15.2 -21.7 -25.8 -25.5 -20.5 -3.9 -7.3 -11.0 -16.8 -25.5
WACC, % 6.34 6.19 6.24 6.19 6.26 6.24 6.24 6.24 6.24 6.24
PV UFCF
SUM PV UFCF -51.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -26
Terminal Value -612
Present Terminal Value -452
Enterprise Value -504
Net Debt -9
Equity Value -494
Diluted Shares Outstanding, MM 5
Equity Value Per Share -108.23

What You Will Receive

  • Pre-Filled Financial Model: Evogene Ltd.’s actual data facilitates accurate DCF valuation.
  • Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential factors.
  • Real-Time Calculations: Automatic updates provide immediate feedback as you adjust inputs.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation presentations.
  • Customizable and Reusable: Designed for adaptability, allowing for multiple applications in detailed forecasting.

Key Features

  • Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Evogene Ltd. (EVGN).
  • WACC Analysis Tool: Features a pre-configured Weighted Average Cost of Capital sheet with adjustable parameters.
  • Customizable Forecast Inputs: Adjust growth projections, capital expenditures, and discount rates as needed.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specifically for Evogene Ltd. (EVGN).
  • Interactive Dashboard and Visuals: Graphical representations highlight essential valuation metrics for straightforward analysis.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Evogene Ltd. (EVGN) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Evogene Ltd.'s (EVGN) intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Evogene Ltd. (EVGN)?

  • Designed for Experts: A sophisticated tool tailored for biotech analysts, investors, and researchers.
  • Comprehensive Data: Evogene’s historical and projected financials are preloaded for precision.
  • Flexible Modeling: Easily test various scenarios and assumptions to gauge potential outcomes.
  • Insightful Results: Automatically computes intrinsic value, NPV, and essential financial metrics.
  • User-Friendly: Step-by-step guidance ensures a smooth experience throughout the process.

Who Should Use This Product?

  • Investors: Accurately assess Evogene Ltd.'s (EVGN) fair value to inform investment choices.
  • CFOs: Utilize a professional-grade DCF model for comprehensive financial reporting and analysis.
  • Consultants: Easily customize the template for client valuation reports related to Evogene Ltd. (EVGN).
  • Entrepreneurs: Discover financial modeling techniques employed by leading biotech firms.
  • Educators: Implement it as a teaching resource to illustrate valuation methodologies in the biotech sector.

What the Template Contains

  • Pre-Filled DCF Model: Evogene Ltd.’s (EVGN) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Evogene Ltd.’s (EVGN) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.